(Q24305184)

vascular endothelial growth factor-activated receptor activity

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

1 reference

1 reference

10

Daniel J Hicklin

0 references

author name string

Jane S Wey

1

0 references

Fan Fan

2

0 references

Michael J Gray

3

0 references

Todd W Bauer

4

0 references

Marya F McCarty

5

0 references

Ray Somcio

6

0 references

Wenbiao Liu

7

0 references

Douglas B Evans

8

0 references

Yan Wu

9

0 references

Lee M Ellis

Expression of vascular endothelial growth factor (VEGF) family members in breast cancer.

11

0 references

language of work or name

English

0 references

publication date

15 July 2005

0 references

published in

Cancer

0 references

volume

104

0 references

issue

2

0 references

page(s)

427-38

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Analysis of PDZ domain-ligand interactions using carboxyl-terminal phage display

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Angiogenesis-independent endothelial protection of liver: role of VEGFR-1.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Chemotherapy for advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Expression of vascular endothelial growth factor receptors in human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

VEGF-RII influences the prognosis of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Cell-density-dependent regulation of actin gene expression due to changes in actin treadmilling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

VEGF blocking therapy in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Prognostic value of vascular endothelial growth factor expression in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Prognostic significance of angiogenesis in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Differential expression of vascular endothelial growth factor-A isoforms at different stages of melanoma progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Isoform-specific expression of VEGF-B in normal tissues and tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Expression of placental growth factor gene in lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21145

7 January 2021

Identifiers

DOI

10.1002/CNCR.21145

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

870360

OpenCitations bibliographic resource ID

870360

1 reference